GS
XLO icon

Gilead Sciences’s Xilio Therapeutics XLO Stock Holding History

Gilead Sciences’s Portfolio XLO Stock Details XLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$6.19M Hold
9,105,451
– – 0.48% 8
2025
Q1 		$6.6M Hold
9,105,451
– – 0.56% 8
2024
Q4 		$8.7M Buy
+9,105,451
New +$8.7M 0.56% 9